4.13
price down icon3.73%   -0.16
after-market アフターアワーズ: 4.18 0.05 +1.21%
loading
前日終値:
$4.29
開ける:
$4.26
24時間の取引高:
1.38M
Relative Volume:
0.59
時価総額:
$682.44M
収益:
$361.51M
当期純損益:
$102.18M
株価収益率:
6.9133
EPS:
0.5974
ネットキャッシュフロー:
$112.21M
1週間 パフォーマンス:
-5.28%
1か月 パフォーマンス:
+11.32%
6か月 パフォーマンス:
+8.97%
1年 パフォーマンス:
+225.20%
1日の値動き範囲:
Value
$4.12
$4.28
1週間の範囲:
Value
$4.045
$4.49
52週間の値動き範囲:
Value
$1.01
$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
名前
Ironwood Pharmaceuticals Inc
Name
セクター
Healthcare (1033)
Name
電話
617-621-7722
Name
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
職員
100
Name
Twitter
@ironwoodpharma
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
IRWD's Discussions on Twitter

Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IRWD icon
IRWD
Ironwood Pharmaceuticals Inc
4.13 684.09M 361.51M 102.18M 112.21M 0.5974
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.24 57.90B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
10.16 43.41B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
36.93 42.89B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
77.17 31.00B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
512.88 22.35B 3.17B 1.29B 1.01B 27.09

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-05 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2025-04-15 ダウングレード Jefferies Buy → Hold
2025-04-15 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 開始されました Leerink Partners Market Perform
2024-08-08 ダウングレード CapitalOne Overweight → Equal Weight
2024-01-17 開始されました Craig Hallum Buy
2023-12-14 開始されました Wells Fargo Overweight
2023-11-09 開始されました Jefferies Buy
2023-09-28 開始されました JMP Securities Mkt Outperform
2022-09-02 開始されました CapitalOne Overweight
2022-04-22 開始されました Piper Sandler Overweight
2020-09-30 ダウングレード Wells Fargo Overweight → Equal Weight
2020-06-17 開始されました Northland Capital Outperform
2019-07-10 再開されました Credit Suisse Neutral
2019-03-27 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-02-25 アップグレード H.C. Wainwright Sell → Neutral
2019-01-24 アップグレード JP Morgan Underweight → Neutral
2018-11-07 ダウングレード Credit Suisse Outperform → Neutral
2018-11-07 ダウングレード JP Morgan Neutral → Underweight
2018-07-23 開始されました H.C. Wainwright Sell
2018-05-09 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-01-05 ダウングレード BofA/Merrill Buy → Underperform
2017-12-06 ダウングレード Mizuho Buy → Neutral
2017-07-21 ダウングレード JP Morgan Overweight → Neutral
2017-05-03 開始されました Wells Fargo Outperform
2017-04-07 繰り返されました Mizuho Buy
2017-02-22 繰り返されました Barclays Equal Weight
2016-11-04 繰り返されました Mizuho Buy
2016-10-24 繰り返されました Wedbush Neutral
2016-10-10 繰り返されました Mizuho Buy
2016-09-27 繰り返されました WallachBeth Hold
すべてを表示

Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース

pulisher
Aug 20, 2026

Ironwood (IRWD) Results Versus Estimates: EPS Does Not Reach the Reported Estimate for the Current Session; Market Move: The Market Price Moves 1.16% Higher in Latest TradingEarnings Yield Analysis - vinanet.vn

Aug 20, 2026
pulisher
Aug 17, 2026

Ironwood Pharmaceuticals (IRWD) Edges Higher: Shares Advance 1.16% as Bulls Defend Key SupportRSI Oversold Picks - vinanet.vn

Aug 17, 2026
pulisher
Aug 16, 2026

Jeffrey Silber Net Worth (2026) - GuruFocus

Aug 16, 2026
pulisher
Aug 16, 2026

Bank of America Corp DE Sells 2,838,753 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 16, 2026
pulisher
Aug 15, 2026

Ironwood Pharmaceuticals | ARS: Annual Report to Security Holders - Moomoo

Aug 15, 2026
pulisher
Aug 15, 2026

Ironwood Pharmaceuticals (IRWD) Q2 2026 Earnings: EPS Misses Estimates, Stock Climbs 5.64%Dividend Growth Analysis - vinanet.vn

Aug 15, 2026
pulisher
Aug 14, 2026

Armistice Capital (IRWD) discloses 13.9M-share Ironwood Pharmaceuticals stake - Stock Titan

Aug 14, 2026
pulisher
Aug 11, 2026

Dimensional Fund Advisors LP Raises Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat

Aug 10, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals, Inc. $IRWD Shares Sold by Amundi - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Downgraded to Buy Rating by Wall Street Zen - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

State Street Corporation (NYSE: IRWD caretaker) holds 5.4% of Ironwood common stock - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

Pacer Advisors Inc. Makes New $3.98 Million Investment in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call High - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed? - Yahoo! Finance Canada

Aug 07, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ... - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

IRWD Looks 15.8% Undervalued on GF Value™ as Debt Reduction Effo - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:IRWD) 2026-08-06 - Seeking Alpha

Aug 06, 2026
pulisher
Aug 06, 2026

Is Ironwood Pharmaceuticals (IRWD) Undervalued After Q2 Earnings - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

IRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Raises 2026 Guidance After Q2 Revenue Hits $113 Million - Quiver Quantitative

Aug 06, 2026
pulisher
Aug 06, 2026

BRIEF-Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Press Release: Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - Moomoo

Aug 06, 2026
pulisher
Aug 06, 2026

Segall Bryant & Hamill LLC Buys New Position in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Lazard Asset Management LLC Sells 710,256 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals (IRWD) Advances 2.89% to $4.27 — Key Resistance at $4.48 in FocusRevenue Growth Stocks - vinanet.vn

Aug 06, 2026
pulisher
Aug 04, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Large Volume IncreaseWhat's Next? - MarketBeat

Aug 04, 2026
pulisher
Aug 01, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to "Hold" at Zacks Research - MarketBeat

Aug 01, 2026
pulisher
Aug 01, 2026

Ironwood Pharmaceuticals (IRWD) Surges 13% as Biotech Momentum BuildsLow Vol Factor - vinanet.vn

Aug 01, 2026
pulisher
Jul 31, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 8.7%Should You Buy? - MarketBeat

Jul 31, 2026
pulisher
Jul 30, 2026

Ironwood Pharmaceuticals Q1 2026 Earnings: Slight EPS Miss Overshadowed by Positive Stock MomentumEPS Revision Trend - vinanet.vn

Jul 30, 2026
pulisher
Jul 28, 2026

Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 28, 2026
pulisher
Jul 28, 2026

BlackRock, Inc. (NASDAQ: IRWD) discloses 8.1% beneficial stake in Ironwood - Stock Titan

Jul 28, 2026
pulisher
Jul 27, 2026

Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Return on assets % of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – BX:I76 - TradingView

Jul 26, 2026
pulisher
Jul 25, 2026

Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – SWB:I76 - TradingView

Jul 25, 2026
pulisher
Jul 25, 2026

Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

IRWD|Ironwood Pharmaceuticals Inc|Price:3.910|Chg%:+0.200 - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

IRWD|Ironwood Pharmaceuticals Inc|Price:3.710|Chg%:-0.080 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Ironwood Pharmaceuticals Inc (I76.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 23, 2026

IRWD: Ironwood Pharmaceuticals IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 23, 2026
pulisher
Jul 23, 2026

Globeflex Capital L P Purchases New Shares in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Jul 23, 2026

Ironwood Pharmaceuticals Inc (IRWD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$48.87
price up icon 1.12%
RDY RDY
$12.22
price up icon 0.33%
$24.42
price up icon 1.88%
$153.04
price up icon 0.00%
$16.54
price up icon 1.35%
$512.88
price down icon 0.05%
大文字化:     |  ボリューム (24 時間):